The society warned that these challenges are making it difficult for many Nigerians living with diabetes and other endocrine and metabolic conditions to obtain proper diagnosis, treatment and long-term medical care.
The concerns were contained in a communiqué issued after EMSON’s 47th Annual General Meeting and Scientific Conference, held in Abuja from September 23 to 25, 2026. The document was signed by the society’s President, Professor Andrew E. Uloko; Secretary-General, Dr Oluwarotimi Olopade; and Publicity Secretary, Professor Michael Olamoyegun.
The organisation said Nigeria was experiencing a growing burden of diabetes, obesity, hypertension, abnormal blood lipid levels and other hormonal and metabolic disorders. However, many patients still face difficulties accessing specialist care, affordable medication, glucose-monitoring equipment and regular follow-up services.
EMSON identified the high cost of insulin, essential endocrine medicines, glucose-monitoring devices and newer treatments for diabetes and obesity as major barriers to effective healthcare delivery.
It also expressed concern over the insufficient number of endocrinologists and their uneven distribution across the country, noting that the migration of trained health professionals was further weakening specialist healthcare capacity.
To address the shortage, the society called for more postgraduate training opportunities in endocrinology and metabolic medicine. It also recommended stronger mentorship programmes, continuous professional development and improved strategies to retain skilled medical personnel.
The society urged the government to ensure a fairer distribution of specialist services across Nigeria’s six geopolitical zones, so that patients outside major urban centres could access appropriate treatment.
It further appealed to the Federal Government, the National Health Insurance Authority and relevant regulatory agencies to expand insurance coverage for endocrine and metabolic conditions, improve access to diagnostic services and make essential medicines and medical technologies more affordable.
On diabetes management, EMSON called for the integration of screening and treatment services into primary and secondary healthcare facilities. It said early diagnosis, blood sugar management, cardiovascular risk assessment and regular screening for complications should form part of comprehensive patient care.
The society also advocated stronger prevention and management strategies for obesity and related metabolic conditions, with lifestyle medicine and multidisciplinary care involving doctors, nutritionists, psychologists, physiotherapists and other specialists.
Women's endocrine health was another area highlighted in the communiqué. EMSON called for improved awareness, screening and treatment of conditions such as polyendocrine metabolic ovarian syndrome (PMOS), menopause and diabetes during pregnancy. It also recommended that relevant services be covered under national health insurance arrangements.
The society raised concerns about paediatric endocrinology, observing that many hormonal and metabolic conditions affecting children and adolescents were not being detected or managed early enough.
It proposed national registries for congenital and rare endocrine disorders, alongside structured transition clinics for adolescents aged 13 to 15. The clinics would allow paediatric and adult endocrinologists to work together during the transfer of young patients to adult healthcare services, helping to maintain continuity of treatment.
EMSON also identified inadequate local research as a challenge to improving endocrine healthcare in Nigeria. It called for increased funding for clinical, epidemiological and translational research, as well as stronger partnerships between Nigerian institutions and international research organisations.
The society maintained that locally generated research evidence would help improve clinical guidelines, public health policies and treatment approaches suited to the country's healthcare needs.
The concerns come amid the growing prevalence of diabetes in Nigeria. The International Diabetes Federation's 2025 Diabetes Atlas estimated that approximately 2.99 million Nigerian adults aged 20 to 79 were living with diabetes in 2024. It also estimated that 78.7 per cent of cases were undiagnosed and projected that the number of adults with diabetes could rise to 6.6 million by 2050 if current trends continue.
The EMSON conference, held under the theme, “Endocrine Practice in Nigeria: Improving Patient Care and Outcomes Through Advocacy,” brought together endocrinologists, diabetologists, family physicians, surgeons, obstetricians and gynaecologists, pharmacists, nurses, laboratory scientists, researchers and policymakers.
The opening ceremony was chaired by the FCT Mandate Secretary for Health Services and Environmental Secretariat, Dr Adedolapo Fasawe, while the keynote address was delivered by Professor Anas Sabir, a former Chief Medical Director of Usmanu Danfodiyo University Teaching Hospital, Sokoto.
The scientific programme featured 56 research papers presented through oral presentations and moderated poster sessions, alongside workshops, symposia and interactive discussions.
At the society's annual general meeting, Professor Andrew E. Uloko was elected president for the 2026–2028 tenure. Other elected officers included Dr Olubiyi Adesina as first vice-president, Professor Christian I. Okafor as second vice-president, Dr Ibitrokoemi F. Korubo as third vice-president and Dr Oluwarotimi Olopade as secretary-general.
EMSON also announced that its 48th Annual General Meeting and Scientific Conference would take place in Enugu State in September 2027.
Reporting by TalkNaijaMedia
Reader Comments (0)
No comments yet. Be the first to share your perspective on this report.